178 related articles for article (PubMed ID: 30905398)
21. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
22. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090).
Cao H; Hegele RA
J Hum Genet; 2003; 48(5):271-274. PubMed ID: 12768443
[TBL] [Abstract][Full Text] [Related]
23. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
[TBL] [Abstract][Full Text] [Related]
24. Mechanics in human fibroblasts and progeria: Lamin A mutation E145K results in stiffening of nuclei.
Apte K; Stick R; Radmacher M
J Mol Recognit; 2017 Feb; 30(2):. PubMed ID: 27677907
[TBL] [Abstract][Full Text] [Related]
25. [Molecular mechanism of pathogenesis of the progeria].
Shimizu T; Yokote K
Nihon Rinsho; 2016 Sep; 74(9):1572-1576. PubMed ID: 30557495
[TBL] [Abstract][Full Text] [Related]
26. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
27. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
[TBL] [Abstract][Full Text] [Related]
28. RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome.
Gruber J; Lampe T; Osborn M; Weber K
J Cell Sci; 2005 Feb; 118(Pt 4):689-96. PubMed ID: 15671064
[TBL] [Abstract][Full Text] [Related]
29. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
[TBL] [Abstract][Full Text] [Related]
30. p.S143F mutation in lamin A/C: a new phenotype combining myopathy and progeria.
Kirschner J; Brune T; Wehnert M; Denecke J; Wasner C; Feuer A; Marquardt T; Ketelsen UP; Wieacker P; Bönnemann CG; Korinthenberg R
Ann Neurol; 2005 Jan; 57(1):148-51. PubMed ID: 15622532
[TBL] [Abstract][Full Text] [Related]
31. [Three cases of Hutchinson-Gilford progeria syndrome].
Doubaj Y; Lamzouri A; Elalaoui SC; Laarabi FZ; Sefiani A
Arch Pediatr; 2011 Feb; 18(2):156-9. PubMed ID: 21251803
[TBL] [Abstract][Full Text] [Related]
32. Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations.
Rivera-Torres J; Calvo CJ; Llach A; Guzmán-Martínez G; Caballero R; González-Gómez C; Jiménez-Borreguero LJ; Guadix JA; Osorio FG; López-Otín C; Herraiz-Martínez A; Cabello N; Vallmitjana A; Benítez R; Gordon LB; Jalife J; Pérez-Pomares JM; Tamargo J; Delpón E; Hove-Madsen L; Filgueiras-Rama D; Andrés V
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7250-E7259. PubMed ID: 27799555
[TBL] [Abstract][Full Text] [Related]
33. Cell autonomous and systemic factors in progeria development.
Osorio FG; Ugalde AP; Mariño G; Puente XS; Freije JM; López-Otín C
Biochem Soc Trans; 2011 Dec; 39(6):1710-4. PubMed ID: 22103512
[TBL] [Abstract][Full Text] [Related]
34. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference.
Huang S; Chen L; Libina N; Janes J; Martin GM; Campisi J; Oshima J
Hum Genet; 2005 Dec; 118(3-4):444-50. PubMed ID: 16208517
[TBL] [Abstract][Full Text] [Related]
35. LMNA mutations in progeroid syndromes.
Huang S; Kennedy BK; Oshima J
Novartis Found Symp; 2005; 264():197-202; discussion 202-7, 227-30. PubMed ID: 15773755
[TBL] [Abstract][Full Text] [Related]
36. Hutchinson-Gilford progeria syndrome.
Pollex RL; Hegele RA
Clin Genet; 2004 Nov; 66(5):375-81. PubMed ID: 15479179
[TBL] [Abstract][Full Text] [Related]
37. Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer.
He T; Zhang Y; Li X; Liu C; Zhu G; Yin X; Zhang Z; Zhao K; Wang Z; Zhao P; Wang K
World J Surg Oncol; 2022 Jun; 20(1):174. PubMed ID: 35650630
[TBL] [Abstract][Full Text] [Related]
38. A 9-year-old Korean girl with Fontaine progeroid syndrome: a case report with further phenotypical delineation and description of clinical course during long-term follow-up.
Ryu J; Ko JM; Shin CH
BMC Med Genet; 2019 Nov; 20(1):188. PubMed ID: 31775791
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.
Goldman RD; Shumaker DK; Erdos MR; Eriksson M; Goldman AE; Gordon LB; Gruenbaum Y; Khuon S; Mendez M; Varga R; Collins FS
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8963-8. PubMed ID: 15184648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
